Compare Becton Dickinson and Co (BDX) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares Core MSCI Emerging Markets ETF — how do they compare? Becton Dickinson and Co trades at $181 (market cap $49.41B), while iShares Core MSCI Emerging Markets ETF trades at $80.97. The key difference: Becton Dickinson and Co pays a 2.32% dividend while iShares Core MSCI Emerging Markets ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, iShares Core MSCI Emerging Markets ETF nearer its low. Which is the better fit depends on your goals.
| BDX | IEMG | |
|---|---|---|
Market Cap | $49.41B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $185.39 | $86.00 |
52-Week Low | $138.62 | $61.76 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $180.64, up 0.56% today, near its consensus price target of $183. The stock shows bullish technical signals with strong moving averages and recent earnings beats in Q2 2026. Revenue growth is steady, with Q3 2026 reaching $5 billion, though margins face pressure from tariffs. The company maintains a Dividend Aristocrat status with consistent payouts.
Outlook is cautiously optimistic with analyst consensus leaning buy, but risks include margin compression and debt levels. The stock offers stability through dividends and sector resilience, yet investors should monitor earnings sustainability and competitive threats in the medical technology space.
IEMG trades at $81.10, up 1.93% with a bullish technical signal from moving averages. The ETF shows strong momentum with 35% trailing returns but faces elevated volatility. Recent news highlights IEMG's 40% technology weighting and AI exposure in emerging markets, though some analysts caution about concentration risks after significant gains.
The outlook remains positive given attractive emerging market valuations and AI-driven growth potential, but investors should monitor volatility and geopolitical risks. The ETF's low 0.09% expense ratio and diversification across 2,700 stocks provide cost-effective exposure to developing economies with superior dividend growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
